Powder -20℃ 3 years; 4℃ 2 years In solvent -80℃ 6 months; -20℃ 1 month
研究领域：
Cardiovascular Disease
Target：
EC50: 8.5 nM (hIP), 530 nM (rIP)[1]
描述：
Ralinepag is a potent, orally bioavailable and non-prostanoid prostacyclin (IP) receptor agonist, with EC50s of 8.5 nM, 530 nM and 850 nM for human and rat IP receptor and human DP1 receptor, respecti
